Sermorelin vs. HGH
Was ist das Richtige für Sie? Kompletter Vergleich (2026)
Sermorelin vs. HGH (Somatropin) vollständiger Vergleich. GHRH-Peptid vs. direkter GH-Ersatz.
Sermorelin vs. HGH: Auf einen Blick
Sermorelin
- ✓Synthetisches GHRH(1-29) – bioaktives Fragment des natürlichen GHRH
- ✓Stimuliert die natürliche pulsatile GH-Freisetzung der Hypophyse
- ✓Früher FDA-zugelassen (Geref) für pädiatrischen GH-Mangel
- ✓Verursacht keine GH-Desensibilisierung bei chronischer Anwendung
- ✓Halbwertszeit ca. 10-20 Minuten
HGH
- ✓Direktes exogenes GH – umgeht die Hypophysen-Signalisierung
- ✓Bietet vorhersagbare, dosisabhängige GH- und IGF-1-Spiegel
- ✓Zugelassen für GH-Mangel, Turner-Syndrom und andere Zustände
- ✓Unterdrückt die körpereigene GH-Produktion während der Anwendung
- ✓Halbwertszeit ca. 3-4 Stunden (tägliche Injektion)
Detaillierter Vergleich
| Merkmal | Sermorelin | HGH |
|---|---|---|
| Mechanismus | GHRH-Analogon | Rekombinantes menschliches Wachstumshormon |
| Dosierung | 200-500 mcg SC täglich vor dem Schlafengehen | 1-4 IU täglich SC (Anti-Aging); höher bei klinischem Mangel |
| Anwendung | Subkutane Injektion | Tägliche subkutane Injektion |
| Halbwertszeit | ~10-20 Minuten | ~3-4 Stunden |
| FDA-Status | Früher zugelassen (kommerziell eingestellt) | Zugelassen (Humatrope, Norditropin etc.) |
Which Should You Choose?
Sermorelin (GRF 1-29) (growth hormone releasing hormone analogue) and Human Growth Hormone (Somatropin) (recombinant human growth hormone) serve different clinical roles despite both being in the GHRH analogue space. Sermorelin (GRF 1-29) synthetic 29-amino-acid analogue of natural ghrh that stimulates physiological gh release from the pituitary. Human Growth Hormone (Somatropin) direct exogenous gh replacement that bypasses the pituitary.
Whichever you choose, track your protocol in Shotlee to build clean data for dose optimization and outcomes comparison.
Track Both in Shotlee
Shotlee supports tracking any medication or peptide. Compare your results across different protocols with clean dose logs and outcome data.
Making an Informed Choice Between Sermorelin and Hgh
Choosing between Sermorelin and Hgh depends on multiple individual factors including your specific health goals, tolerance profile, insurance coverage, and prescriber recommendation. While clinical trial data provides population-level efficacy and safety comparisons, your personal response may differ based on genetics, baseline health, concurrent conditions, and lifestyle factors. Use this comparison as a starting framework and discuss the specifics with your healthcare provider.
Head-to-head clinical trial data between Sermorelin and Hgh is the gold standard for comparison, but such direct comparisons are not always available for every pair of compounds. Where head-to-head data is lacking, cross-trial comparisons provide useful but imperfect approximations — differences in patient populations, trial design, and endpoint definitions mean that numbers from separate trials are not directly interchangeable. Keep this context in mind when evaluating the comparison data presented here.
Tracking your personal response data in Shotlee is particularly valuable when switching between medications or considering a change. By documenting your outcomes on your current protocol — including efficacy metrics, side effect profile, adherence rate, and quality of life measures — you create an objective baseline for comparison if you transition to the alternative compound. This data transforms a subjective switching decision into an evidence-based protocol optimization.
Sermorelin vs Hgh: Häufig gestellte Fragen
Sermorelin stimuliert die Hypophyse, eigenes GH freizusetzen, wodurch der natürliche Regelkreis erhalten bleibt. HGH ist ein direkter Ersatz, der die eigene Produktion unterdrückt.
Quellen
- [1]Clinical TrialVittone J, et al. "Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men." Metabolism. 1997;46(1):89-96.
- [2]Clinical TrialRudman D, et al. "Effects of human growth hormone in men over 60 years old." N Engl J Med. 1990;323(1):1-6.
- [3]ReviewLiu H, et al. "Systematic review: the safety and efficacy of growth hormone in the healthy elderly." Ann Intern Med. 2007;146(2):104-115.
- [4]Clinical TrialKhorram O, et al. "Two years of treatment with recombinant human growth hormone-releasing hormone (sermorelin) in healthy elderly men." J Clin Endocrinol Metab. 1997;82(11):3590-3596.
Sermorelin oder Hgh in Shotlee tracken
Kostenloses Dosis-Tracking, Protokollierung von Nebenwirkungen und Ergebnisvergleich für jedes Medikamentenprotokoll.
🚀 Shotlee kostenlos nutzen